Quote | Healthcare Capital Corp. Unit (NASDAQ:HCCCU)
Last: | $12.875 |
---|---|
Change Percent: | 12.94% |
Open: | $11.96 |
Close: | $12.875 |
High: | $14.35 |
Low: | $11.96 |
Volume: | 1,739 |
Last Trade Date Time: | 03/07/2022 04:54:57 pm |
News | Healthcare Capital Corp. Unit (NASDAQ:HCCCU)
NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) and Alpha Tau Medical Ltd. (“Alpha Tau”), an Israeli medical device company that focuses on research, development, and pote...
NEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) today announced that on February 15, 2022 it convened and then adjourned, without conducting any other business, its special meeting of stockholders...
Message Board Posts | Healthcare Capital Corp. Unit (NASDAQ:HCCCU)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Healthcare Capital Corp. Unit Company Name:
HCCCU Stock Symbol:
NASDAQ Market:
NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) and Alpha Tau Medical Ltd. (“Alpha Tau”), an Israeli medical device company that focuses on research, development, and pote...
NEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) today announced that on February 15, 2022 it convened and then adjourned, without conducting any other business, its special meeting of stockholders...
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer PR Newswire JERUSALEM , Jan. 20, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of t...